Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 14

Imidafenacin, An Orally Active Muscarinic Receptor Antagonist, Improves Pulmonary Function In Patients With Chronic Obstructive Pulmonary Disease: A Multicenter, Randomized, Double-Blind, Placebo-Controlled 3×3 Crossover Phase II Trial

Total article views   HTML views PDF downloads Totals
9,048 Dovepress* 8,416+ 1,487 9,903
PubMed Central* 632 247 879
Totals 9,048 1,734 10,782
*Since 19 September 2019
Total mentioned Facebook Delicious Reddit Twitter Others
20 2 0 0 8 10

View citations on PubMed Central and Google Scholar